NIAID Banner Logo Image

ONLINE DATABASE SEARCH - HIV-LS-315-MEMO

1. 44792 HIV-LS-315; SCIFINDER-HIV-2/1/2005

Antiviral Function of APOBEC3G Can Be Dissociated from Cytidine Deaminase Activity

Newman, Edmund NC, Holmes, Rebecca K, Craig, Heather M, Klein, Kevin C, Lingappa, Jaisri R, Malim, Michael H, and Sheehy, Ann M

Current Biology 2005. 15(2): 166-170


2. 44793 HIV-LS-315; PUBMED-HIV-2/9/2005

Dissecting the Effects of DNA Polymerase and Ribonuclease H Inhibitor Combinations on HIV-1 Reverse-Transcriptase Activities

Shaw-Reid, CA, Feuston, B, Munshi, V, Getty, K, Krueger, J, Hazuda, DJ, Parniak, MA, Miller, MD, and Lewis, D

Biochemistry 2005. 44(5): 1595-1606


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15683243&dopt=abstract


3. 44794 HIV-LS-315; SCIFINDER-HIV-2/1/2005

Synthesis and antiviral activity of novel acyclic nucleosides in the 5-alkynyl- and 6-alkylfuro[2,3-d]pyrimidine series

Amblard, Franck, Aucagne, Vincent, Guenot, Pierre, Schinazi, Raymond F, and Agrofoglio, Luigi A

Bioorganic & Medicinal Chemistry 2005. 13(4): 1239-1248


4. 44795 HIV-LS-315; PUBMED-HIV-2/9/2005

Caffeine inhibits human immunodeficiency virus type 1 transduction of nondividing cells

Daniel, R, Marusich, E, Argyris, E, Zhao, RY, Skalka, AM, and Pomerantz, RJ

J Virol 2005. 79(4): 2058-65


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15681408&dopt=abstract


5. 44796 HIV-LS-315; SCIFINDER-HIV-2/1/2005

VCAM-1 Expression on CD8+ Cells Correlates with Enhanced Anti-HIV Suppressing Activity

Diaz, Leyla S, Foster, Hillary, Stone, Mars R, Fujimura, Sue, Relman, David A, and Levy, Jay A

Journal of Immunology 2005. 174(3): 1574-1579


6. 44797 HIV-LS-315; PUBMED-HIV-2/9/2005

Mechanism of action and resistant profile of anti-HIV-1 coumarin derivatives

Huang, L, Yuan, X, Yu, D, Lee, KH, and Ho, Chen C

Virology 2005. 332(2): 623-8


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15680427&dopt=abstract



7. 44798 HIV-LS-315; SCIFINDER-HIV-2/1/2005

Indole, azaindole and related heterocyclic n-substituted piperazine derivatives

Yeung, Kap-Sun, Farkas, Michelle, Kadow, John F, Meanwell, Nicholas A, Taylor, Malcolm, Johnston, David, Coulter, Thomas Stephen, and Wright, JJKim

PATENT: WO 2005004801 ISSUE DATE: 20050120

APPLICATION: 2004 PP: 226 pp.

ASSIGNEE: (Bristol-Myers Squibb Company, USA


8. 44799 HIV-LS-315; SCIFINDER-HIV-2/1/2005

Human Immunodeficiency Virus Protease Inhibitors Accumulate into Cultured Human Adipocytes and Alter Expression of Adipocytokines

Vernochet, Cecile, Azoulay, Stephane, Duval, Daniele, Guedj, Roger, Cottrez, Francoise, Vidal, Hubert, Ailhaud, Gerard, and Dani, Christian

Journal of Biological Chemistry 2005. 280(3): 2238-2243


9. 44800 HIV-LS-315; SCIFINDER-HIV-2/1/2005

Methods for treatment of HIV or malaria using combinations of chloroquine and protease inhibitors

Savarino, Andrea

PATENT: US 20050009810 ISSUE DATE: 20050113

APPLICATION: 2004-62372 PP: 20 pp.

ASSIGNEE: (Italy)


10. 44801 HIV-LS-315; SCIFINDER-HIV-2/1/2005

Antiviral compounds derived from naturally occurring proteins

Pellegrini, Antonio and Engels, Monika

Current Medicinal Chemistry: Anti-Infective Agents 2005. 4(1): 55-66


11. 44802 HIV-LS-315; PUBMED-HIV-2/9/2005

Pharmacokinetics, pharmacodynamics and drug interaction potential of enfuvirtide

Patel, IH, Zhang, X, Nieforth, K, Salgo, M, and Buss, N

Clin Pharmacokinet 2005. 44(2): 175-86


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15656696&dopt=abstract


12. 44803 HIV-LS-315; PUBMED-HIV-2/9/2005

Resistance to dual nucleoside reverse-transcriptase inhibitors in children infected with HIV clade A/E

Lolekha, R, Sirivichayakul, S, Siangphoe, U, Pancharoen, C, Kaewchana, S, Apateerapong, W, Mahanontharit, A, Chotpitayasunondh, T, Ruxrungtham, K, Phanuphak, P, and Ananworanich, J

Clin Infect Dis 2005. 40(2): 309-12


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15655753&dopt=abstract



13. 44804 HIV-LS-315; SCIFINDER-HIV-2/1/2005

PEM-3-like proteins and encoding nucleic acids and their use in antiviral therapy and drug screening

Greener, Tsvika and Ben-Avraham, Danny

PATENT: WO 2005001485 ISSUE DATE: 20050106

APPLICATION: 2004 PP: 175 pp.

ASSIGNEE: (Proteologics, Inc. USA


14. 44805 HIV-LS-315; SCIFINDER-HIV-2/1/2005

Compositions for down-regulation of CCR5 expression and reducing HIV entry into T-cells

Redfield, Robert R, Amoroso, Anthony, Davis, Charles E, and Heredia, Alonsa

PATENT: WO 2005001027 ISSUE DATE: 20050106

APPLICATION: 2004 PP: 58 pp.

ASSIGNEE: (University of Maryland Biotechnology Institute, USA


15. 44806 HIV-LS-315; PUBMED-HIV-2/9/2005

Rationale for maintenance of the M184v resistance mutation in human immunodeficiency virus type 1 reverse transcriptase in treatment experienced patients

Turner, D, Brenner, BG, Routy, JP, Petrella, M, and Wainberg, MA

New Microbiol 2004. 27(2 Suppl 1): 31-9


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15646062&dopt=abstract


16. 44807 HIV-LS-315; WOS-HIV-1/30/2005

Inhibition of HIV-1 infection by monoclonal antibodies to carbohydrates of Schistosoma mansoni

Antonio, M, Mello, G, Mascarenhas, RE, Ferraro, GA, Harn, D, Galvao-Castro, B, and Bou-Habib, DC

MEDICAL MICROBIOLOGY AND IMMUNOLOGY 2005. 194(1-2): 61-65, 5


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226096200009


17. 44808 HIV-LS-315; WOS-HIV-1/30/2005

Enfuvirtide, first fusion inhibitor in the treatment of human immunodeficiency virus infection - Action mechanism and pharmacokinetics

Raffi, F

MEDECINE ET MALADIES INFECTIEUSES 2004. 34: 3-7, 5


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000225859300002


18. 44809 HIV-LS-315; WOS-HIV-1/30/2005

Antibodies that are cross-reactive for human immunodeficiency virus type 1 clade A and clade B V3 domains are common in patient sera from cameroon, but their neutralization activity is usually restricted by epitope masking

Krachmarov, C, Pinter, A, Honnen, WJ, Gorny, MK, Nyambi, PN, Zolla-Pazner, S, and Kayman, SC

JOURNAL OF VIROLOGY 2005. 79(2): 780-790, 11


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226149700013



19. 44810 HIV-LS-315; WOS-HIV-1/30/2005

Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1

Zwick, MB, Jensen, R, Church, S, Wang, M, Stiegler, G, Kunert, R, Katinger, H, and Burton, DR

JOURNAL OF VIROLOGY 2005. 79(2): 1252-1261, 10


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226149700059


20. 44811 HIV-LS-315; WOS-HIV-1/30/2005

Changes in the vif protein of HIV-1 associated with the development of resistance to inhibitors of viral protease

Adekale, MA, Cane, PA, and McCrae, MA

JOURNAL OF MEDICAL VIROLOGY 2005. 75(2): 195-201, 7


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226009400003


21. 44812 HIV-LS-315; WOS-HIV-1/30/2005

Advances in the diagnosis and treatment of acute human immunodeficiency virus type 1 (HIV-1) infection

Miro, JM, Sued, O, Plana, M, Pumarola, T, and Gallart, T

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 2004. 22(10): 643-659, 17


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226008500003


22. 44813 HIV-LS-315; WOS-HIV-1/30/2005

Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases

Sarafianos, SG, Das, K, Hughes, SH, and Arnold, E

CURRENT OPINION IN STRUCTURAL BIOLOGY 2004. 14(6): 716-730, 15


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226045600012


23. 44814 HIV-LS-315; WOS-HIV-1/30/2005

Cyclo-oxygenase type 2-dependent prostaglandin E-2 secretion is involved in retrovirus-induced T-cell dysfunction in mice

Rahmouni, S, Aandahl, EM, Nayjib, B, Zeddou, M, Giannini, S, Verlaet, M, Greimers, R, Boniver, J, Tasken, K, and Moutschen, M

BIOCHEMICAL JOURNAL 2004. 384: 469-476, 8


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226084000003


24. 44815 HIV-LS-315; WOS-HIV-1/30/2005

Inhibition of HIV type 1 replication using lentiviral-mediated delivery of mutant tRNA(Lys3) A58U

Renda, MJ, Bradel-Tretheway, B, Planelles, V, Bambara, RA, and Dewhurst, S

AIDS RESEARCH AND HUMAN RETROVIRUSES 2004. 20(12): 1324-1334, 11


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226049200007


25. 44816 HIV-LS-315; WOS-HIV-2/6/2005

HIV-1 incorporates and proteolytically processes human NDR1 and NDR2 serine-threonine kinases

Devroe, E, Silver, PA, and Engelman, A

VIROLOGY 2005. 331(1): 181-189, 9


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226210500017


26. 44817 HIV-LS-315; WOS-HIV-2/6/2005

New analogues of the antitumor alkaloid girolline: The 4-deazathiogirolline series

Nay, B, Schiavi, B, Ahond, A, Poupat, C, and Potier, P

SYNTHESIS-STUTTGART 2005.(1): 97-101, 5


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226258700016


27. 44818 HIV-LS-315; WOS-HIV-2/6/2005

Human immunodeficiency virus - one of nature's greatest evolutionary machines

Martin, D and Williamson, C

SOUTH AFRICAN JOURNAL OF SCIENCE 2004. 100(9-10): 479-482, 4


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226240500020


28. 44819 HIV-LS-315; WOS-HIV-2/6/2005

Pharmacokinetic and metabolic studies of retrojusticidin B, a potential anti-viral lignan, in rats

Wang, CY, Sun, SW, and Lee, SS

PLANTA MEDICA 2004. 70(12): 1161-1165, 5


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226292900011


29. 44820 HIV-LS-315; WOS-HIV-2/6/2005

Changes in the SU can modulate the susceptibility of feline immunodeficiency virus to TM-derived entry inhibitors

Giannecchini, S, Pistello, M, Del, Santo B, Rovero, P, Sichi, O, and Bendinelli, M

MICROBIOLOGICA 2004. 27(2): 77-84, 8


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226119200011


30. 44821 HIV-LS-315; WOS-HIV-2/6/2005

A new prospective against HIV infection: Induction of murin CCR5-downregulating antibodies

Barassi, C, Marenzi, C, Pastori, C, Longhi, R, Lazzarin, A, and Lopalco, L

MICROBIOLOGICA 2004. 27(2): 85-94, 10


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226119200012


31. 44822 HIV-LS-315; WOS-HIV-2/6/2005

Tuftsin-AZT conjugate: potential macrophage targeting for AIDS therapy

Fridkin, M, Tsubery, H, Tzehoval, E, Vonsover, A, Biondi, L, Filira, F, and Rocchi, R

JOURNAL OF PEPTIDE SCIENCE 2005. 11(1): 37-44, 8


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226391100005


32. 44823 HIV-LS-315; WOS-HIV-2/6/2005

Study on the interactions between anti-HIV-1 active compounds with trans-activation response RNA by affinity capillary electrophoresis

Li, D, Zhang, XX, Chang, WB, Wei, L, and Yang, M

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES 2005. 814(1): 99-104, 6


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226272100013



33. 44824 HIV-LS-315; WOS-HIV-2/6/2005

Constituents from the stems of Hibiscus taiwanensis

Wu, PL, Wu, TS, He, CX, Su, CH, and Lee, KH

CHEMICAL & PHARMACEUTICAL BULLETIN 2005. 53(1): 56-59, 4


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226329000012


34. 44825 HIV-LS-315; WOS-HIV-2/6/2005

Topochemical model for prediction of anti-HIV activity of HEPT analogs

Bajaj, S, Sambi, SS, and Madan, AK

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 2005. 15(2): 467-469, 3


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226344800042


35. 44826 HIV-LS-315; WOS-HIV-2/6/2005

Anti-HIV benzylisoquinoline alkaloids and flavonoids from the leaves of Nelumbo nucifera, and structure-activity correlations with related alkaloids

Kashiwada, Y, Aoshima, A, Ikeshiro, Y, Chen, YP, Furukawa, H, Itoigawa, M, Fujioka, T, Mihashi, K, Cosentino, LM, Morris-Natschke, SL, and Lee, KH

BIOORGANIC & MEDICINAL CHEMISTRY 2005. 13(2): 443-448, 6


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000226343800014


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2019